1. Home
  2. SRPT vs STRRP Comparison

SRPT vs STRRP Comparison

Compare SRPT & STRRP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRPT
  • STRRP
  • Stock Information
  • Founded
  • SRPT 1980
  • STRRP N/A
  • Country
  • SRPT United States
  • STRRP United States
  • Employees
  • SRPT N/A
  • STRRP 194
  • Industry
  • SRPT Biotechnology: Pharmaceutical Preparations
  • STRRP Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • SRPT Health Care
  • STRRP Health Care
  • Exchange
  • SRPT Nasdaq
  • STRRP Nasdaq
  • Market Cap
  • SRPT 1.7B
  • STRRP N/A
  • IPO Year
  • SRPT 1997
  • STRRP N/A
  • Fundamental
  • Price
  • SRPT $17.97
  • STRRP $9.23
  • Analyst Decision
  • SRPT Buy
  • STRRP
  • Analyst Count
  • SRPT 25
  • STRRP 0
  • Target Price
  • SRPT $61.57
  • STRRP N/A
  • AVG Volume (30 Days)
  • SRPT 7.9M
  • STRRP N/A
  • Earning Date
  • SRPT 08-06-2025
  • STRRP N/A
  • Dividend Yield
  • SRPT N/A
  • STRRP N/A
  • EPS Growth
  • SRPT N/A
  • STRRP N/A
  • EPS
  • SRPT N/A
  • STRRP N/A
  • Revenue
  • SRPT $2,233,371,000.00
  • STRRP N/A
  • Revenue This Year
  • SRPT $26.87
  • STRRP N/A
  • Revenue Next Year
  • SRPT $3.15
  • STRRP N/A
  • P/E Ratio
  • SRPT N/A
  • STRRP N/A
  • Revenue Growth
  • SRPT 59.15
  • STRRP N/A
  • 52 Week Low
  • SRPT $16.88
  • STRRP N/A
  • 52 Week High
  • SRPT $154.13
  • STRRP N/A
  • Technical
  • Relative Strength Index (RSI)
  • SRPT 28.43
  • STRRP 55.69
  • Support Level
  • SRPT $17.31
  • STRRP $9.01
  • Resistance Level
  • SRPT $19.74
  • STRRP $9.29
  • Average True Range (ATR)
  • SRPT 1.04
  • STRRP 0.03
  • MACD
  • SRPT 0.87
  • STRRP 0.03
  • Stochastic Oscillator
  • SRPT 45.83
  • STRRP 82.86

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

About STRRP Star Equity Holdings Inc. Series A Cumulative Perpetual Preferred Stock

Star Equity Holdings Inc is a multi-industry diversified holding company. It operates in two segments: Building Solutions segment, through KBS, EBGL and TT, it services residential and commercial construction projects by manufacturing modular housing units, structural wall panels, permanent wood foundation systems, other engineered wood products, and supply general contractors with building materials; and Investments segment, which holds corporate-owned real estate, currently includes one manufacturing facility and the equipment for another manufacturing facility in Maine that it leases back to KBS and its manufacturing facility in Wisconsin that it leases back to TT. The company derives maximum revenue from Building Solutions Segment.

Share on Social Networks: